Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)

This study has been terminated.
(Slow Accrual)
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: July 8, 2010
Last updated: March 23, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2016
  Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)